This trial is Ruxolitnib versus hydroxycarbamide or interferon as first line therapy in high risk PV.
I am 69 female diagnosed ET 2 years ago but diagnosis changed to PV 1 year ago. My worse symptom was pruritus which I had been plagued with since 2015. I was prescribed hydrea and ever increasing doses decreased the platelets; the other bloods weren't ideal but low enough to cause some fatigue. However, the itching continued to dominate my life.
With the Mithridate trial I had a 50% chance of being put on Ruxolitnib which offered a good chance of being rid of the itching. I took a chance, the chance being if randomised to stay on hydrea I was committing to 3 years and so wouldn't switch to interferon. I am very pleased to say I was lucky and got Rux and am now 1 month into the trial. The itch stopped within days, I just have an inflamed burning sensation over my knees which is negligible compared to itching. It has changed my life. Unfortunately, platelets are back up and low RBC and low HCT means I still hit a brick wall most days, but nothing awful. However, it is very early days, I am being monitored closely and feel I am getting very good care. I am hoping that my haematologist will be able to juggle the dosage and stabilize my bloods so I can continue on Rux and be rid of the itch forever.
Hope this information and the trial will help others.